对于复发性Clostridiodes difficile感染而进行便微生物群移植及其全球监管格局
Isha Deepti1, Bijaya Chettri1, Anjali Mehra1
1Department of Pharmaceutical Regulatory Affairs and Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
The Indian journal of medical research
|April 21, 2025
概括
便微生物种移植 (FMT) 有效地治疗复发性Clostridioides difficile感染 (rCDI). 这种治疗涉及健康的供体便,通过潜在地减少抗生素耐药性,为公众健康带来好处.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 复发性Clostridioides difficile感染 (rCDI) 是一个重大的全球健康挑战,特别影响老年人群.
- 便微生物种移植 (FMT) 是一项长期存在的手术,涉及将健康捐赠者的肠道微生物引入患者.
- 最近FDA对FMT产品 (Vowst,Rebyota) 的批准强调了其日益增长的临床认可.
研究的目的:
- 对复发性Clostridioides difficile感染 (rCDI) 进行便微生物种移植 (FMT) 的现有情况进行审查.
- 讨论全球FMT相关的监管状况和挑战.
- 强调公共卫生影响和未来的FMT实施方向.
主要方法:
- 关于FMT疗效,监管和挑战的文献综述.
- 对FMT产品的全球监管框架的分析.
- 对rCDI.FMT的公共卫生前景进行讨论.
主要成果:
- FMT是对rCDI的公认和有效治疗方法,有新兴的FDA批准的产品.
- 在不同的国家 (美国,英国,欧洲,澳大利亚) 中,对FMT的监管方法有很大差异.
- 除了rCDI外,FMT由于其肠道菌群调节效应,显示出其他疾病的潜力.
结论:
- FMT是对rCDI的关键公共卫生干预,有可能制抗生素过度使用和耐药性.
- 主要挑战包括产品标准化,道德考虑,数据安全和可访问性.
- 通过诸如通用便银行之类的倡议,简化捐助者选择和分配对于更广泛的实施至关重要.
相关概念视频
01:50What is Monogastric Digestion?
69.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
69.6K
01:29Bacterial Flora of the Large Intestine
359
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
359
01:21Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109
01:17Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
01:21Inflammatory Bowel Disease V: Surgical Management
59
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
59